These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 38509409)

  • 1. Ferroptosis mechanisms and regulations in cardiovascular diseases in the past, present, and future.
    Fang W; Xie S; Deng W
    Cell Biol Toxicol; 2024 Mar; 40(1):17. PubMed ID: 38509409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Insights into the Role of Ferroptosis in Cardiovascular Diseases.
    Fratta Pasini AM; Stranieri C; Busti F; Di Leo EG; Girelli D; Cominacini L
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Iron Metabolism and Ferroptosis as Novel Therapeutic Approaches in Cardiovascular Diseases.
    Chen Y; Li X; Wang S; Miao R; Zhong J
    Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferroptosis as a novel therapeutic target for cardiovascular disease.
    Wu X; Li Y; Zhang S; Zhou X
    Theranostics; 2021; 11(7):3052-3059. PubMed ID: 33537073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferroptosis in Cardiovascular Diseases: Current Status, Challenges, and Future Perspectives.
    Guo Y; Lu C; Hu K; Cai C; Wang W
    Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decoding ferroptosis: Revealing the hidden assassin behind cardiovascular diseases.
    Zhang Z; Yang Z; Wang S; Wang X; Mao J
    Biomed Pharmacother; 2024 Jul; 176():116761. PubMed ID: 38788596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferroptosis and its emerging roles in cardiovascular diseases.
    Li N; Jiang W; Wang W; Xiong R; Wu X; Geng Q
    Pharmacol Res; 2021 Apr; 166():105466. PubMed ID: 33548489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noncoding RNAs regulating ferroptosis in cardiovascular diseases: novel roles and therapeutic strategies.
    Wu C; Bao S; Sun H; Chen X; Yang L; Li R; Peng Y
    Mol Cell Biochem; 2024 Nov; 479(11):2827-2841. PubMed ID: 38064139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Link Between Ferroptosis and Cardiovascular Diseases: A Novel Target for Treatment.
    Hu H; Chen Y; Jing L; Zhai C; Shen L
    Front Cardiovasc Med; 2021; 8():710963. PubMed ID: 34368260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease.
    Fang X; Ardehali H; Min J; Wang F
    Nat Rev Cardiol; 2023 Jan; 20(1):7-23. PubMed ID: 35788564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferroptosis and its role in cardiomyopathy.
    Li D; Pi W; Sun Z; Liu X; Jiang J
    Biomed Pharmacother; 2022 Sep; 153():113279. PubMed ID: 35738177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Mechanisms of Ferroptosis and Relevance to Cardiovascular Disease.
    Xie LH; Fefelova N; Pamarthi SH; Gwathmey JK
    Cells; 2022 Sep; 11(17):. PubMed ID: 36078133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular mechanisms of ferroptosis and its role in cardiovascular disease.
    Zhang Y; Xin L; Xiang M; Shang C; Wang Y; Wang Y; Cui X; Lu Y
    Biomed Pharmacother; 2022 Jan; 145():112423. PubMed ID: 34800783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifaceted role of ferroptosis in cardiovascular disease.
    Li C; Zhu X; Chen J; Xie X; Liang S; Liu X; Gong Q; Guo J
    Acta Biochim Biophys Sin (Shanghai); 2023 Feb; 55(2):183-193. PubMed ID: 36815377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of ferroptosis in diabetic cardiovascular diseases and the intervention of active ingredients of traditional Chinese medicine.
    Zhang X; Sun J; Wang J; Meng T; Yang J; Zhou Y
    Front Pharmacol; 2023; 14():1286718. PubMed ID: 37954843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferroptotic Cell Death: New Regulatory Mechanisms for Metabolic Diseases.
    Le Y; Zhang Z; Wang C; Lu D
    Endocr Metab Immune Disord Drug Targets; 2021; 21(5):785-800. PubMed ID: 32735532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging regulatory mechanisms in cardiovascular disease: Ferroptosis.
    Jin S; Wang H; Zhang X; Song M; Liu B; Sun W
    Biomed Pharmacother; 2024 May; 174():116457. PubMed ID: 38518600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferroptosis in Cardiovascular Disease and Cardiomyopathies: Therapeutic Implications of Glutathione and Iron Chelating Agents.
    Dawi J; Affa S; Gonzalez E; Misakyan Y; Nikoghosyan D; Hajjar K; Kades S; Fardeheb S; Mirzoyan H; Venketaraman V
    Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferroptosis, a Regulated Form of Cell Death, as a Target for the Development of Novel Drugs Preventing Ischemia/Reperfusion of Cardiac Injury, Cardiomyopathy and Stress-Induced Cardiac Injury.
    Ryabov VV; Maslov LN; Vyshlov EV; Mukhomedzyanov AV; Kilin M; Gusakova SV; Gombozhapova AE; Panteleev OO
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting ferroptosis: a novel insight against myocardial infarction and ischemia-reperfusion injuries.
    Han X; Zhang J; Liu J; Wang H; Du F; Zeng X; Guo C
    Apoptosis; 2023 Feb; 28(1-2):108-123. PubMed ID: 36474078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.